Cargando…

Clinical and molecular characterization of primary hyperoxaluria in Egypt

Primary hyperoxaluria (PH) is an autosomal recessive disorder of oxalate metabolism caused by pathogenic variants in either of three genes (AGXT, GRHPR or HOGA1). The study aimed at characterizing the clinical phenotypes as well as the genotypic spectrum of PH in Egypt. We screened 25 Egyptian patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Soliman, Neveen A., Elmonem, Mohamed A., Abdelrahman, Safaa M., Nabhan, Marwa M., Fahmy, Yosra A., Cogal, Andrea, Harris, Peter C., Milliner, Dawn S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508166/
https://www.ncbi.nlm.nih.gov/pubmed/36151119
http://dx.doi.org/10.1038/s41598-022-17980-9
_version_ 1784796962837495808
author Soliman, Neveen A.
Elmonem, Mohamed A.
Abdelrahman, Safaa M.
Nabhan, Marwa M.
Fahmy, Yosra A.
Cogal, Andrea
Harris, Peter C.
Milliner, Dawn S.
author_facet Soliman, Neveen A.
Elmonem, Mohamed A.
Abdelrahman, Safaa M.
Nabhan, Marwa M.
Fahmy, Yosra A.
Cogal, Andrea
Harris, Peter C.
Milliner, Dawn S.
author_sort Soliman, Neveen A.
collection PubMed
description Primary hyperoxaluria (PH) is an autosomal recessive disorder of oxalate metabolism caused by pathogenic variants in either of three genes (AGXT, GRHPR or HOGA1). The study aimed at characterizing the clinical phenotypes as well as the genotypic spectrum of PH in Egypt. We screened 25 Egyptian patients suspected of PH for the three responsible genes by Sanger sequencing. We diagnosed 20 patients from 18 unrelated families, in which the natural history, family history, clinical features and genotypes were evaluated. PH patients were 15 males and 5 females ranging in age from 4 months to 31 years (median 8 years). Fifteen families were consanguineous (83%) and familial clustering was reported in six families (33%). Pathogenic variants in all 40 alleles were in AGXT, with none detected in GRHPR or HOGA1. We detected two novel pathogenic variants c.166-1_172dupGATCATGG (p.Asp58Glyfs*65) and c.766delC (p.Gln256fs*16) and seven previously reported variants in our cohort. This is the first study reporting the genotype of a considerable number of PH1 patients from Egypt. Our detected variants in the AGXT gene could form the basis for future genetic counseling and prenatal diagnosis in Egypt and surrounding populations.
format Online
Article
Text
id pubmed-9508166
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-95081662022-09-25 Clinical and molecular characterization of primary hyperoxaluria in Egypt Soliman, Neveen A. Elmonem, Mohamed A. Abdelrahman, Safaa M. Nabhan, Marwa M. Fahmy, Yosra A. Cogal, Andrea Harris, Peter C. Milliner, Dawn S. Sci Rep Article Primary hyperoxaluria (PH) is an autosomal recessive disorder of oxalate metabolism caused by pathogenic variants in either of three genes (AGXT, GRHPR or HOGA1). The study aimed at characterizing the clinical phenotypes as well as the genotypic spectrum of PH in Egypt. We screened 25 Egyptian patients suspected of PH for the three responsible genes by Sanger sequencing. We diagnosed 20 patients from 18 unrelated families, in which the natural history, family history, clinical features and genotypes were evaluated. PH patients were 15 males and 5 females ranging in age from 4 months to 31 years (median 8 years). Fifteen families were consanguineous (83%) and familial clustering was reported in six families (33%). Pathogenic variants in all 40 alleles were in AGXT, with none detected in GRHPR or HOGA1. We detected two novel pathogenic variants c.166-1_172dupGATCATGG (p.Asp58Glyfs*65) and c.766delC (p.Gln256fs*16) and seven previously reported variants in our cohort. This is the first study reporting the genotype of a considerable number of PH1 patients from Egypt. Our detected variants in the AGXT gene could form the basis for future genetic counseling and prenatal diagnosis in Egypt and surrounding populations. Nature Publishing Group UK 2022-09-23 /pmc/articles/PMC9508166/ /pubmed/36151119 http://dx.doi.org/10.1038/s41598-022-17980-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Soliman, Neveen A.
Elmonem, Mohamed A.
Abdelrahman, Safaa M.
Nabhan, Marwa M.
Fahmy, Yosra A.
Cogal, Andrea
Harris, Peter C.
Milliner, Dawn S.
Clinical and molecular characterization of primary hyperoxaluria in Egypt
title Clinical and molecular characterization of primary hyperoxaluria in Egypt
title_full Clinical and molecular characterization of primary hyperoxaluria in Egypt
title_fullStr Clinical and molecular characterization of primary hyperoxaluria in Egypt
title_full_unstemmed Clinical and molecular characterization of primary hyperoxaluria in Egypt
title_short Clinical and molecular characterization of primary hyperoxaluria in Egypt
title_sort clinical and molecular characterization of primary hyperoxaluria in egypt
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508166/
https://www.ncbi.nlm.nih.gov/pubmed/36151119
http://dx.doi.org/10.1038/s41598-022-17980-9
work_keys_str_mv AT solimanneveena clinicalandmolecularcharacterizationofprimaryhyperoxaluriainegypt
AT elmonemmohameda clinicalandmolecularcharacterizationofprimaryhyperoxaluriainegypt
AT abdelrahmansafaam clinicalandmolecularcharacterizationofprimaryhyperoxaluriainegypt
AT nabhanmarwam clinicalandmolecularcharacterizationofprimaryhyperoxaluriainegypt
AT fahmyyosraa clinicalandmolecularcharacterizationofprimaryhyperoxaluriainegypt
AT cogalandrea clinicalandmolecularcharacterizationofprimaryhyperoxaluriainegypt
AT harrispeterc clinicalandmolecularcharacterizationofprimaryhyperoxaluriainegypt
AT millinerdawns clinicalandmolecularcharacterizationofprimaryhyperoxaluriainegypt